S. Pollard

655 total citations
10 papers, 481 citations indexed

About

S. Pollard is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, S. Pollard has authored 10 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology and Allergy. Recurrent topics in S. Pollard's work include Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (4 papers) and Allergic Rhinitis and Sensitization (4 papers). S. Pollard is often cited by papers focused on Asthma and respiratory diseases (9 papers), Respiratory and Cough-Related Research (4 papers) and Allergic Rhinitis and Sensitization (4 papers). S. Pollard collaborates with scholars based in United States, United Kingdom and Spain. S. Pollard's co-authors include Henry Milgrom, William Berger, Anjuli Nayak, Niroo Gupta, Patricia Rohane, Fred M. Cox, Amanda Emmett, Steven W. Yancey, Sheldon L. Spector and J. Wesley Sublett and has published in prestigious journals such as PEDIATRICS, Journal of Allergy and Clinical Immunology and Annals of Allergy Asthma & Immunology.

In The Last Decade

S. Pollard

10 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Pollard United States 6 453 306 247 62 45 10 481
Tracy Bridges United States 3 259 0.6× 252 0.8× 107 0.4× 48 0.8× 26 0.6× 3 332
Ayman Megally United States 8 361 0.8× 179 0.6× 161 0.7× 17 0.3× 112 2.5× 15 425
Mary Buatti Small United States 6 495 1.1× 396 1.3× 70 0.3× 10 0.2× 78 1.7× 7 546
О М Курбачева Russia 10 169 0.4× 63 0.2× 162 0.7× 11 0.2× 59 1.3× 106 311
Katrien Eger Netherlands 9 205 0.5× 144 0.5× 68 0.3× 4 0.1× 62 1.4× 12 288
Nkiruka Erekosima United States 7 411 0.9× 82 0.3× 432 1.7× 3 0.0× 28 0.6× 7 500
Sean O’Quinn United States 9 138 0.3× 145 0.5× 39 0.2× 4 0.1× 31 0.7× 21 249
P. Rufin France 8 195 0.4× 183 0.6× 87 0.4× 57 0.9× 2 0.0× 36 304
M. Piquer Spain 8 82 0.2× 26 0.1× 122 0.5× 6 0.1× 11 0.2× 17 165
Pontus Mertsch Germany 8 43 0.1× 93 0.3× 18 0.1× 2 0.0× 13 0.3× 32 162

Countries citing papers authored by S. Pollard

Since Specialization
Citations

This map shows the geographic impact of S. Pollard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Pollard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Pollard more than expected).

Fields of papers citing papers by S. Pollard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Pollard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Pollard. The network helps show where S. Pollard may publish in the future.

Co-authorship network of co-authors of S. Pollard

This figure shows the co-authorship network connecting the top 25 collaborators of S. Pollard. A scholar is included among the top collaborators of S. Pollard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Pollard. S. Pollard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lee, Jason K., S. Pollard, Mark C. Liu, et al.. (2025). Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma. Annals of Allergy Asthma & Immunology. 135(1). 37–46. 4 indexed citations
2.
Lee, Jason T., S. Pollard, Mark Liu, et al.. (2022). Influence of Baseline Total IgE and History of Previous Omalizumab Use on the Impact of Mepolizumab in Reducing Rate of Severe Asthma Exacerbations: Results From the Real-World REALITI-A Study. Journal of Allergy and Clinical Immunology. 149(2). AB191–AB191. 1 indexed citations
3.
Schleich, Florence, Rekha Chaudhuri, Giorgio Walter Canonica, et al.. (2020). Mepolizumab improves lung function under real-world settings in REALITI-A study. 2260–2260. 1 indexed citations
4.
Sublett, J. Wesley, et al.. (2016). Comparison of systemic reactions in rush, cluster, and standard-build aeroallergen immunotherapy. Annals of Allergy Asthma & Immunology. 117(5). 542–545. 24 indexed citations
5.
Massanari, Marc, Henry Milgrom, S. Pollard, et al.. (2009). Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate—Severe Allergic Asthma. Clinical Pediatrics. 48(8). 859–865. 20 indexed citations
6.
Pollard, S., Robert Maykut, Marc Massanari, et al.. (2007). Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma. Journal of Allergy and Clinical Immunology. 119(1). S10–S10. 1 indexed citations
7.
Milgrom, Henry, William Berger, Anjuli Nayak, et al.. (2001). Treatment of Childhood Asthma With Anti-Immunoglobulin E Antibody (Omalizumab). PEDIATRICS. 108(2). e36–e36. 382 indexed citations
8.
9.
Weinstein, Steven F., Paul Chervinsky, S. Pollard, et al.. (1997). A One-Week Dose-Ranging Study of Inhaled Salmeterol in Children with Asthma. Journal of Asthma. 34(1). 43–52. 16 indexed citations
10.
Pollard, S., Sheldon L. Spector, Steven W. Yancey, Fred M. Cox, & Amanda Emmett. (1997). Salmeterol Versus Theophylline in the Treatment of Asthma. Annals of Allergy Asthma & Immunology. 78(5). 457–464. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracy Bridges Breakdown of academic impact, for papers by Ayman Megally Breakdown of academic impact, for papers by Mary Buatti Small Breakdown of academic impact, for papers by О М Курбачева Breakdown of academic impact, for papers by Katrien Eger Breakdown of academic impact, for papers by Nkiruka Erekosima Breakdown of academic impact, for papers by Sean O’Quinn Breakdown of academic impact, for papers by P. Rufin Breakdown of academic impact, for papers by M. Piquer Breakdown of academic impact, for papers by Pontus Mertsch
Rankless by CCL
2026